| scholarly article | Q13442814 |
| P2093 | author name string | M Kang | |
| M M Lederman | |||
| D D Anthony | |||
| E T Overton | |||
| J A Aberg | |||
| K Medvik | |||
| M G Peters | |||
| M J Koziel | |||
| T Umbleja | |||
| P2860 | cites work | Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen. ACTG 375 team. AIDS Clinical Trials Group. | Q52028396 |
| Nadir CD4+ T-cell count and numbers of CD28+ CD4+ T-cells predict functional responses to immunizations in chronic HIV-1 infection. | Q53855050 | ||
| Identification of a New Subset of Myeloid Suppressor Cells in Peripheral Blood of Melanoma Patients With Modulation by a Granulocyte-Macrophage Colony-Stimulation Factor–Based Antitumor Vaccine | Q60311223 | ||
| Dendritic cells and macrophages can mature independently from a human bone marrow-derived, post-colony-forming unit intermediate | Q71099867 | ||
| Immunogenicity and safety of an inactivated hepatitis A vaccine in anti-HIV positive and negative homosexual men | Q71923414 | ||
| Cultures derived from peripheral blood CD34+ progenitor cells of head and neck cancer patients and from cord blood are functionally different | Q73336565 | ||
| Hepatitis B immunization of healthy elderly adults: relationship between naïve CD4+ T cells and primary immune response and evaluation of GM-CSF as an adjuvant | Q73803218 | ||
| Overview of vaccines | Q73957921 | ||
| Granulocyte macrophage colony stimulating factor (GM-CSF) induced sero-protection in end stage renal failure patients to hepatitis B in vaccine non-responders | Q77299049 | ||
| Mechanisms of immune suppression in patients with head and neck cancer: presence of CD34(+) cells which suppress immune functions within cancers that secrete granulocyte-macrophage colony-stimulating factor | Q22008006 | ||
| Myeloid-derived suppressor cells as regulators of the immune system | Q28131637 | ||
| Overview of the pathogenesis, prophylaxis and therapeusis of viral hepatitis B, with focus on reduction to practical applications | Q32067250 | ||
| Immune response to hepatitis B vaccine in HIV-infected subjects using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant: ACTG study 5220. | Q34147433 | ||
| The cellular basis for lack of antibody response to hepatitis B vaccine in humans | Q36230016 | ||
| Opposite immune functions of GM-CSF administered as vaccine adjuvant in cancer patients | Q36658673 | ||
| Special regulatory T cell review: The resurgence of the concept of contrasuppression in immunoregulation | Q37043735 | ||
| Regulatory conversation between antigen presenting cells and regulatory T cells enhance immune suppression | Q37099752 | ||
| Efficacy of granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant for hepatitis B virus in patients with HIV infection | Q44176096 | ||
| Characterization of hepatitis B virus surface antigen-specific CD4+ T cells in hepatitis B vaccine non-responders | Q44369168 | ||
| Hepatitis A vaccine responses in HIV-positive persons with haemophilia | Q44531135 | ||
| Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study | Q45413375 | ||
| Safety and Immunogenicity of Hepatitis A Vaccine in Human Immunodeficiency Virus–Infected Patients: A Double‐Blind, Randomized, Placebo‐Controlled Trial | Q45726048 | ||
| Granulocyte-macrophage colony-stimulating factor enhances the efficacy of hepatitis B virus vaccine in previously unvaccinated haemodialysis patients | Q45745542 | ||
| Prethymic CD34+ progenitors capable of developing into T cells are not committed to the T cell lineage. | Q51104185 | ||
| Peripheral blood dendritic cells and GM-CSF as an adjuvant for hepatitis B vaccination in hemodialysis patients. | Q51999308 | ||
| P433 | issue | 19 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3558-3563 | |
| P577 | publication date | 2011-03-11 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Lower peripheral blood CD14+ monocyte frequency and higher CD34+ progenitor cell frequency are associated with HBV vaccine induced response in HIV infected individuals | |
| P478 | volume | 29 |
| Q40761860 | Expansion of myeloid-derived suppressor cells promotes differentiation of regulatory T cells in HIV-1+ individuals. |
| Q41358662 | Granulocyte-macrophage stimulating factor (GM-CSF) increases circulating dendritic cells but does not abrogate suppression of adaptive cellular immunity in patients with metastatic colorectal cancer receiving chemotherapy |
| Q35055364 | Hepatitis B virus large surface protein: function and fame. |
| Q28388716 | Immune activation alters cellular and humoral responses to yellow fever 17D vaccine |
| Q58694800 | Improved CD4 T cell profile in HIV-infected subjects on maraviroc-containing therapy is associated with better responsiveness to HBV vaccination |
| Q38492085 | Insights into Myeloid-Derived Suppressor Cells in Inflammatory Diseases |
| Q33604622 | Monocytes from chronic HBV patients react in vitro to HBsAg and TLR by producing cytokines irrespective of stage of disease |
| Q42771123 | Optimized dosing of a CCR2 antagonist for amplification of vaccine immunity |
| Q27000664 | Reciprocal relationship between myeloid-derived suppressor cells and T cells |
| Q28086980 | Significant roles of regulatory T cells and myeloid derived suppressor cells in hepatitis B virus persistent infection and hepatitis B virus-related HCCs |
| Q26774875 | The Role of Immune Cells in Chronic HBV Infection |
Search more.